Spire Healthcare Group (LON:SPI) Stock Price Down 20% – Time to Sell?

Spire Healthcare Group plc (LON:SPI)’s share price dropped 20% during trading on Monday . The company traded as low as GBX 148.83 and last traded at GBX 151.80. Approximately 45,061,531 shares were traded during trading, an increase of 1,005% from the average daily volume of 4,078,339 shares. The stock had previously closed at GBX 189.74.

Spire Healthcare Group Stock Down 18.1%

The business has a fifty day moving average of GBX 193.65 and a 200 day moving average of GBX 205.56. The company has a quick ratio of 0.74, a current ratio of 0.63 and a debt-to-equity ratio of 177.14. The firm has a market cap of £625.28 million, a P/E ratio of 33.78, a P/E/G ratio of 1.06 and a beta of 0.71.

Spire Healthcare Group (LON:SPI) last issued its earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%. On average, equities research analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.